The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Effects of Cigarette Smoking on Spatial Working Memory and Attentional Deficits in Schizophrenia: Involvement of Nicotinic Receptor Mechanisms
Abstract
BACKGROUND: Cigarette smoking rates in schizophrenia are higher than in the general population. OBJECTIVES: To determine whether cigarette smoking modifies cognitive deficits in schizophrenia and to establish the role of nicotinic acetylcholine receptors (nAChRs) in mediating cigarette smoking-related cognitive enhancement. DESIGN: Neuropsychological assessments were performed at smoking baseline, after overnight abstinence, and after smoking reinstatement across 3 separate test weeks during which subjects were pretreated in a counterbalanced manner with the nonselective nAChR antagonist mecamylamine hydrochloride (0, 5, or 10 mg/d). PARTICIPANTS: Twenty-five smokers with schizophrenia and 25 control smokers. SETTING: Outpatient mental health center. MAIN OUTCOME MEASURES: Visuospatial working memory (VSWM) and Continuous Performance Test (CPT) scores. RESULTS: In smokers with schizophrenia and control smokers, overnight abstinence led to undetectable plasma nicotine levels and an increase in tobacco craving. While abstinence reduced CPT hit rate in both groups, VSWM was only impaired in smokers with schizophrenia. Smoking reinstatement reversed abstinence-induced cognitive impairment. Enhancement of VSWM and CPT performance by smoking reinstatement in smokers with schizophrenia, but not the subjective effects of smoking, was blocked by mecamylamine treatment. CONCLUSIONS: Cigarette smoking may selectively enhance VSWM and attentional deficits in smokers with schizophrenia, which may depend on nAChR stimulation. These findings may have implications for understanding the high rates of smoking in schizophrenia and for developing pharmacotherapies for cognitive deficits and nicotine dependence in schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696 · cited 2×
“39 Changes in mood were assessed using the Beck Depression Inventory.”
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,086
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
(1995) · Cited by 2,809
Cohen, J., MacWhinney, B., Flatt, M., & Provost, J. (1993) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03204507 · Cited by 2,802
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058
The development and initial validation of a questionnaire on smoking urges
TIFFANY, S. T., & DROBES, D. J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01732.x · Cited by 974
Schizophrenics Show Spatial Working Memory Deficits
Park, S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120063009 · Cited by 945
SOBELL, L. C., SOBELL, M. B., LEO, G. I., & CANCILLA, A. (1988) · British Journal of Addiction · doi:10.1111/j.1360-0443.1988.tb00485.x · Cited by 776
Schizophrenia, sensory gating, and nicotinic receptors
Adler, L. E., Olincy, A., Waldo, M., Harris, J. G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S., et al. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033320 · Cited by 690
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Nicotine Dependence in Schizophrenia: Clinical Phenomena and Laboratory Findings
Dalack, G. W., Healy, D. J., & Meador-Woodruff, J. H. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1490 · Cited by 498
Leonard, S., Gault, J., Hopkins, J., Logel, J., Vianzon, R., Short, M., Drebing, C., Berger, R., Venn, D., Sirota, P., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.12.1085 · Cited by 441
Goldman-Rakic, P. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00130-4 · Cited by 419
George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J., Rounsaville, B. J., & Kosten, T. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1835 · Cited by 354
Self-citationAbnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia
Breese, C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 345
Nicotine-Haloperidol Interactions and Cognitive Performance in Schizophrenics
Levin, E. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00018-8 · Cited by 342
Kelly, C., & McCreadie, R. G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1751 · Cited by 317
Mishara, A. L., & Goldberg, T. E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.027 · Cited by 310
Dopamine, the prefrontal cortex and schizophrenia
Knable, M. B., & Weinberger, D. R. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100205 · Cited by 303
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
George, T. P., Vessicchio, J. C., Termine, A., Bregartner, T. A., Feingold, A., Rounsaville, B. J., & Kosten, T. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01339-2 · Cited by 292
Self-citationCigarette Smoking Among Adults—United States, 1994
(1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540080019009 · Cited by 270
Analysis of Mecamylamine Stereoisomers on Human Nicotinic Receptor Subtypes
Papke, R. L., Sanberg, P. R., & Shytle, R. D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29581-1 · Cited by 269
Cholinergic gating of response to auditory stimuli in rat hippocampus
Luntz-Leybman, V., Bickford, P. C., & Freedman, R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91437-j · Cited by 264
Olincy, A., Young, D. A., & Freedman, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00302-2 · Cited by 252
Smith, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00324-x · Cited by 247
Effects of Nicotine on Cognitive Deficits in Schizophrenia
Harris, J. G., Kongs, S., Allensworth, D., Martin, L., Tregellas, J., Sullivan, B., Zerbe, G., & Freedman, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300450 · Cited by 237
Smoking Cessation Treatment for Patients With Schizophrenia
Addington, J., el-Guebaly, N., Campbell, W., Hodgins, D. C., & Addington, D. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.974 · Cited by 229
Effects of Smoking Abstinence on Visuospatial Working Memory Function in Schizophrenia
George, T. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00296-2 · Cited by 226
Self-citationSchizophrenia and Nicotinic Receptors
Freedman, R., Adler, L. E., Bickford, P., Byerley, W., Coon, H., Cullum, M. C., Griffith, J. M., Harris, J. G., Leonard, S., Miller, C., et al. (1994) · Harvard Review of Psychiatry · doi:10.3109/10673229409017136 · Cited by 217
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200
Ichikawa, J., Li, Z., Dai, J., & Meltzer, H. Y. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03570-9 · Cited by 196
Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110073920 · Cited by 191
Swick, D., & Jovanovic, J. (2002) · Neuropsychologia · doi:10.1016/s0028-3932(01)00226-3 · Cited by 190
Hahn, B., Shoaib, M., & Stolerman, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1005-6 · Cited by 188
Hariharan, M., VanNoord, T., & Greden, J. F. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.4.724 · Cited by 183
Probing Prefrontal Function in Schizophrenia With Neuropsychological Paradigms
Goldberg, T. E., & Weinberger, D. R. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.179 · Cited by 182
Dépatie, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00372-x · Cited by 175
Word and Tone Working Memory Deficits in Schizophrenia
Wexler, B. E., Stevens, A. A., Bowers, A. A., Sernyak, M. J., & Goldman-Rakic, P. S. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1093 · Cited by 173
Self-citationKeefe, R. S. E., Lees Roitman, S. E., Harvey, P. D., Blum, C. S., DuPre, R. L., Prieto, D. M., Davidson, M., & Davis, K. L. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00027-j · Cited by 172
Dissociating the nicotine and airway sensory effects of smoking
Westman, E. C., Behm, F. M., & Rose, J. E. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02027-6 · Cited by 154
Smoking and Vulnerability for Schizophrenia
de León, J. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.405 · Cited by 145
Rats with lesions of the hippocampus are impaired on the delayed nonmatching‐to‐sample task†
Clark, R. E., West, A. N., Zola, S. M., & Squire, L. R. (2001) · Hippocampus · doi:10.1002/hipo.1035 · Cited by 139
Estimating WAIS IQ from the shipley institute of living scale using continuously adjusted age norms
Zachary, R. A., Paulson, M. J., & Gorsuch, R. L. (1985) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198511)41:6<820::aid-jclp2270410616>3.0.co;2-x · Cited by 137
Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior
NEWHOUSE, P. A., Potter, A., Corwin, J., & Lenox, R. H. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.11 · Cited by 137
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
D, A. O. M. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00095-x · Cited by 136
Simosky, J. K., Stevens, K. E., Adler, L. E., & Freedman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1285-x · Cited by 121
Effects of nicotine withdrawal on central dopaminergic systems
Fung, Y. K., Schmid, M. J., Anderson, T. M., & Lau, Y. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02063-2 · Cited by 117
Hildebrand, B. E., Panagis, G., Svensson, T. H., & Nomikos, G. G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 110
The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control
Decker, M. W., Meyer, M. D., & Sullivan, J. P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1819 · Cited by 102
Vezina, P., Blanc, G., Glowinski, J., & Tassin, J. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11064-1 · Cited by 101
A CONVENIENT SELF-ADMINISTERING SCALE FOR MEASURING INTELLECTUAL IMPAIRMENT IN PSYCHOTICS
Shipley, W. C., & Burlingame, C. C. (1941) · American Journal of Psychiatry · doi:10.1176/ajp.97.6.1313 · Cited by 98
Mecamylamine: new therapeutic uses and toxicity/risk profile
Young, J. M., Shytle, R. D., Sanberg, P. R., & George, T. P. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80059-x · Cited by 96
Self-citationThe Continuous Performance Test.
Mirsky, A. F. (2007) · Basic Books · doi:10.1037/11420-013 · Cited by 89
Roll, J. M., Higgins, S. T., Steingard, S., & McGinley, M. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.2.157 · Cited by 88
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
McChargue, D. E., Gulliver, S. B., & Hitsman, B. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00064.x · Cited by 88
The Stroop effect in schizophrenic patients
Hepp, H. H., Maier, S., Hermle, L., & Spitzer, M. (1996) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00080-1 · Cited by 87
Management of smoking in people with psychiatric disorders
Ziedonis, D. M., & Williams, J. M. (2003) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000069086.26384.5f · Cited by 85
Avila, M. T., Sherr, J. D., Hong, E. L., Myers, C. S., & Thaker, G. K. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300265 · Cited by 82
D, A. O. M., Johnson, L. L., & Ross, R. G. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00022-2 · Cited by 80
Blockade of Smoking Satisfaction Using the Peripheral Nicotinic Antagonist Trimethaphan
Rose, J. E., Westman, E. C., Behm, F. M., Johnson, M. P., & Goldberg, J. S. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00153-1 · Cited by 80
Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking
Dallery, J., Houtsmuller, E. J., Pickworth, W. B., & Stitzer, M. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1242-8 · Cited by 68
George, T. P., Verrico, C. D., Picciotto, M. R., & Roth, R. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38869-x · Cited by 66
Self-citationMecamylamine does not precipitate withdrawal in cigarette smokers
Eissenberg, T., Griffiths, R. R., & Stitzer, M. L. (1996) · Psychopharmacology · doi:10.1007/s002130050094 · Cited by 62
George, T. P., Verrico, C. D., & Roth, R. H. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00537-x · Cited by 44
Self-citationTidey, J. W., Higgins, S. T., Bickel, W. K., & Steingard, S. (1999) · Psychopharmacology · doi:10.1007/s002130051031 · Cited by 41
Nicotine-mecamylamine interactions
Zevin, S., Jacob, P., & Benowitz, N. L. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108066 · Cited by 23
The effect of nicotine and haloperidol co-treatment on nicotinic receptor levels in the rat brain
Lee, M. J., Breese, C. R., Strook, M. L., & Leonard, S. S. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00274-6 · Cited by 17
Leonard, S. S., & Giordano, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00382-2 · Cited by 11
Cited by
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Self-citationWorking memory in schizophrenia: a meta-analysis
Forbes, N. F., Carrick, L. A., McIntosh, A. M., & Lawrie, S. M. (2009) · Psychological Medicine · doi:10.1017/s0033291708004558 · Cited by 550
PICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 460
Initial phase 2 trial of a nicotinic agonist in schizophrenia
Freedman, R., Olincy, A., Buchanan, R. W., Harris, J. G., Gold, J. M., Johnson, L., Allensworth, D., Guzman-Bonilla, A., Clement, B., Ball, M. P., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07071135 · Cited by 426
Bickel, W. K., Jarmolowicz, D. P., Mueller, E. T., Gatchalian, K. M., & McClure, S. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2689-x · Cited by 317
Metadata
- Authors
- Sacco, K. A., Termine, A., Seyal, A., Dudas, M. M., Vessicchio, J. C., Krishnan-Sarin, S., Jatlow, P. I., Wexler, B. E., & George, T. P.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2005-06-01
- Volume
- 62
- Issue
- 6
- Pages
- 649
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2121948831
- Cited by
- 330
- References
- 75
- FWCI
- 14.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.